文献速递颈动脉与弓上血管

血管质量倡议:经股动脉颈动脉支架术后30天卒中/死亡风险评分计算器

The Vascular Quality Initiative 30-day stroke/death risk score calculator after transfemoral carotid artery stenting.
PubMed 文献 · J Vasc Surg · 2019-09-13

本研究基于血管质量倡议(VQI)2010至2018年数据,纳入10,753例经股动脉颈动脉支架术(TFCAS)患者,旨在开发预测术后30天卒中/死亡的风险评分。多因素分析识别出年龄、非白种人、糖尿病、冠心病、充血性心力衰竭、症状性状态及对侧闭塞等独立预测因子,而他汀和双联抗血小板治疗则与风险降低相关。模型C统计量为69.0%,并据此构建了风险评分计算器,但需外部验证。

要点

  • TFCAS术后30天卒中/死亡率为4.1%,症状性患者风险显著增高(OR 2.11)。
  • 术前使用他汀(OR 0.074)和双联抗血小板治疗(OR 0.46)与风险降低独立相关。
  • 基于7项预测因子构建的风险评分计算器C统计量为69.0%,尚需外部验证。

核心结论

  • 年龄、非白种人、症状性状态、糖尿病、冠心病、充血性心力衰竭和对侧闭塞是TFCAS术后30天卒中/死亡的独立预测因子。
  • 术前使用他汀和双联抗血小板治疗与TFCAS术后30天卒中/死亡风险显著降低相关。
  • 基于上述变量开发的风险评分计算器可估算TFCAS术后30天卒中/死亡概率,但需外部验证。

研究设计与样本

  • 研究分析了血管质量倡议(VQI)CAS数据集2010至2018年的数据。
  • 共纳入10,753例接受经股动脉颈动脉支架术(TFCAS)的患者。
  • 排除创伤、夹层、经颈动脉支架术及未使用栓塞保护装置的病例。
  • 采用单变量和多变量逻辑回归(bootstrapping 1000次重复)筛选预测因子,通过逐步后退法简化模型。

主要发现

  • 总体30天卒中/死亡率为4.1%。
  • 独立预测因子包括:年龄(OR 1.05,95%CI 1.03-1.06,P<.001)、非白种人(OR 1.42,95%CI 1.16-1.74,P=.001)、糖尿病(OR 1.34,95%CI 1.08-1.67,P=.01)、冠心病(OR 1.40,95%CI 1.13-1.73,P=.001)、充血性心力衰竭(OR 1.41,95%CI 1.07-1.85,P=.02)、症状性状态(OR 2.11,95%CI 1.64-2.72,P<.001)、对侧闭塞(OR 1.64,95%CI 1.22-2.19,P=.001)。
  • 术前使用他汀(OR 0.074,95%CI 0.59-0.93,P=.02)和双联抗血小板治疗(OR 0.46,95%CI 0.32-0.66,P<.001)与风险降低相关。
  • 模型C统计量为69.0%。

关键数值与推荐

  • 风险评分计算器通过将各预测因子的回归系数转换为整数来估算30天卒中/死亡概率。
  • 评分被分组为简化类别。

临床怎么用

  • 该风险评分计算器可用于TFCAS术前评估患者30天卒中/死亡风险,辅助临床决策。
  • 术前使用他汀和双联抗血小板治疗可能降低TFCAS术后卒中/死亡风险。

局限性

  • 该工具需在不同患者人群和数据集中进行外部验证以评估其预测性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Carotid artery stenting (CAS) was introduced as an alternative carotid revascularization procedure in patients deemed to be at high risk for carotid endarterectomy. Although techniques and selection criteria for patients have dramatically improved, CAS continues to have higher risk of stroke and death in comparison to carotid endarterectomy. Several risk factors are known to be associated with worse outcomes. Whereas knowledge of these independent factors is helpful, clinical decision-making is further refined when these are considered in aggregate. This study aimed to develop a score to predict the risk of stroke/death after transfemoral CAS (TFCAS). METHODS: We analyzed the Vascular Quality Initiative CAS data set from 2010 to 2018. Lesions due to trauma, dissection, or transcarotid artery stenting and cases performed without an embolic protection device were excluded. Univariable and multivariable logistic regression methods with bootstrapping (1000 repetitions) were used to identify predictors associated with 30-day stroke/death. Stepwise backward selection for variables was used to achieve model parsimony. A risk score was made by converting regression coefficients for each predictor to integers from which probability was calculated. Scores were grouped into simplified categories. RESULTS: We identified 10,753 patients undergoing TFCAS during the study period with a combined 30-day stroke/death rate of 4.1%. On multivariable adjustment, independent predictors of 30-day stroke/death included age (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.03-1.06; P < .001), nonwhite race (OR, 1.42; 95% CI, 1.16-1.74; P = .001), diabetes (OR,1.34; 95% CI, 1.08-1.67; P = .01), coronary artery disease (OR, 1.40; 95% CI, 1.13-1.73; P = .001), congestive heart failure (OR, 1.41; 95% CI, 1.07-1.85; P = .02), symptomatic status (OR, 2.11; 95% CI, 1.64-2.72; P < .001), and contralateral occlusion (OR, 1.64; 95% CI, 1.22-2.19; P = .001). On the other hand, preoperative use of statins (OR, 0.074; 95% CI, 0.59-0.93; P = .02) and dual antiplatelet therapy (P2Y12 inhibitors and aspirin; OR, 0.46; 95% CI, 0.32-0.66; P < .001) were associated with a significant reduction in stroke/death after TFCAS. The model had a C statistic of 69.0%. The coefficients of these predictors were used to develop a risk score calculator that estimates the probability of 30-day stroke/death after TFCAS. CONCLUSIONS: In an analysis of 10,753 patients undergoing TFCAS between 2010 and 2018, significant predictors of perioperative stroke or death included old age, nonwhite race, symptomatic status, diabetes, coronary artery disease, congestive heart failure, and contralateral occlusion in addition to perioperative dual antiplatelet therapy and statin use. These variables were used to develop a risk score calculator that estimates the probability of 30-day stroke/death after TFCAS. External validation of this tool in different populations of patients and data sets is warranted to evaluate its predictive performance.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dakour-Aridi H, Faateh M, Kuo PL, et al. The Vascular Quality Initiative 30-day stroke/death risk score calculator after transfemoral carotid artery stenting. J Vasc Surg. 2019. PMID: 31526692. doi:10.1016/j.jvs.2019.05.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。